Mostrar el registro sencillo del ítem

dc.contributor.authorPérez de los Cobos, José
dc.contributor.authorAlcaraz, Saul
dc.contributor.authorSiñol, Núria
dc.contributor.authorGonzález-Saiz, Francisco
dc.contributor.authorVergara-Moragues, Esperanza (1)
dc.date2020-07
dc.date.accessioned2020-08-10T09:04:07Z
dc.date.available2020-08-10T09:04:07Z
dc.identifier.issn0376-8716
dc.identifier.urihttps://reunir.unir.net/handle/123456789/10379
dc.description.abstractBackground: Patient satisfaction with methadone or buprenorphine-naloxone can be multidimensionally and specifically assessed by using, respectively, the Scale to Assess Satisfaction with Medications for Addiction Treatment–Methadone for Heroin addiction (SASMAT-METHER) or the SASMAT–Buprenorphine-Naloxone for Heroin addiction (SASMAT-BUNHER). The factor structures of the SASMAT-METHER and SASMAT-BUNHER show substantial commonalities. The objective of the present study is to evaluate the replicability of the SASMAT-METHER factor structure using data from the SASMAT-BUNHER development study in order to obtain an instrument that can be used to compare patient satisfaction with methadone vs. buprenorphine-naloxone. Method: Secondary analysis of SASMAT-BUNHER data provided by 205 participants in the original validation study of that scale (Pérez de los Cobos et al., 2018). Using the SASMAT-METHER component solution (17 items, 3 factors) as the target structure, a principal component analysis was performed on the data set comprised of the corresponding 17 SASMAT-BUNHER items using an oblique semi-specified Procrustean rotation. Additionally, Tucker congruence coefficients were computed to examine the correspondence between the two solutions. Result: The factor structures of SASMAT-METHER and the 17-item version of the SASMAT-BUNHER can be considered equal given that the overall Tucker's congruence coefficient of factorial similarity was 0.972, with individual component congruencies ranging from 0.960 to 0.995. Conclusions: The SASMAT-METHER component solution can serve as a single common tool to compare methadone vs. buprenorphine-naloxone in terms of patient satisfaction. This finding supports the feasibility of using a common metric to specifically assess satisfaction with medications to treat heroin dependence.es_ES
dc.language.isoenges_ES
dc.publisherDrug and Alcohol Dependencees_ES
dc.relation.ispartofseries;vol. 212, nº 1
dc.relation.urihttps://www.sciencedirect.com/science/article/abs/pii/S0376871620301757?via%3Dihubes_ES
dc.rightsrestrictedAccesses_ES
dc.subjectpatient satisfactiones_ES
dc.subjectopioides_ES
dc.subjectfactor structurees_ES
dc.subjectreplicabilityes_ES
dc.subjectmethadonees_ES
dc.subjectbuprenorphine-naloxonees_ES
dc.subjectScopuses_ES
dc.subjectJCRes_ES
dc.titleTowards a common metric for assessing heroin-dependent patient satisfaction with medications: Testing methadone and buprenorphine-naloxonees_ES
dc.typeArticulo Revista Indexadaes_ES
reunir.tag~ARIes_ES
dc.identifier.doihttps://doi.org/10.1016/j.drugalcdep.2020.108010


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem